Suggestions
Scott Glenn
Chairman/Founder at GLO Pharma/Ourself
Professional Background
Scott Glenn is a distinguished entrepreneur and seasoned leader in the life sciences and healthcare industries, known for his impressive track record in founding and leading successful ventures. He has held key roles in multiple pioneering firms that have significantly advanced medical technology and innovation. As a former Chairman and Founder of Rebalance Health, Scott played an essential role in redefining health management and access to healthcare solutions. His strategic vision and leadership have been instrumental in fostering growth and development in various organizations, notably within the biopharmaceutical sector.
With a solid foundation in corporate leadership, Scott has also served as the Founder and Chairman of GLOPHARMA, where he directed initiatives aimed at improving global healthcare accessibility. His extensive experience includes serving as the Managing Partner at Windamere Venture Partners, where he provided essential guidance and mentorship to emerging companies within the venture capital landscape.
Additionally, Scott Glenn's remarkable career comprises multiple founding and leadership roles at innovative businesses such as Prometheus Biosciences, Inc., VelosBio, ALASTIN Skincare, Inc., and Oncternal Therapeutics. His ability to envision and launch groundbreaking products speaks to his entrepreneurial spirit and deep understanding of market needs. Notably, he has been a pivotal figure in nurturing Cadence Inc. and SkinMedica Inc., An Allergan Company, demonstrating his prowess in the life sciences sector.
One of Scott’s significant roles was as Chairman and Founder of Dexcom, a leader in Continuous Glucose Monitoring (CGM) technology that has transformed diabetes management for patients worldwide. This innovation not only exemplifies Scott's dedication to healthcare improvement but also showcases his ability to navigate complex market demands and develop impactful solutions.
Moreover, his tenure at Santarus, Inc. and Prometheus Laboratories Inc. reinforced his reputation as an entrepreneur who champions the development of novel therapeutics and diagnostics in the pharmaceutical industry. His leadership played a key role in advancing these initiatives through strategic partnerships, product development, and effective commercialization processes.
Scott's journey also included serving as the Chairman and CEO at Quidel, where he directed company strategy and paved the way for innovative diagnostics in the healthcare domain. His comprehensive understanding of the healthcare landscape has undoubtedly positioned him as a thought leader in the field.
In addition to these leadership roles, Scott was the Division General Manager at Allergan, where he gained valuable experience in management and product development, further strengthening his capability to foster innovation in healthcare.
Education and Achievements
Scott Glenn's educational background equips him with a resilient framework for his entrepreneurial endeavors. Although the specific institutions and degrees he acquired are not specified, his extensive career and practical insights into the healthcare industry undoubtedly reflect a commitment to lifelong learning and professional growth.
Over the years, he has built a reputation for not only leading successful ventures but also for developing a supportive ecosystem for innovation in healthcare. With a keen eye for identifying opportunities, Scott has mentored many aspiring entrepreneurs and offered guidance, thereby significantly contributing to the growth of the life sciences ecosystem.
Achievements
Scott’s achievements are vast and include the successful launch of several companies focused on enhancing patient care and advancing healthcare technology. Each organization he has led or founded has contributed to his growing legacy as a leader who promotes health innovation. Some of his most notable accomplishments include:
- Innovation in Diabetes Management: As Chairman and Founder of Dexcom, Scott made groundbreaking contributions to glucose monitoring, empowering patients to take control of their diabetes care with cutting-edge technology.
- Advancing Therapeutics: His tenure at Prometheus Biosciences and Oncternal Therapeutics highlights his commitment to developing innovative treatments for serious diseases, showcasing his ability to bridge science with real-world healthcare applications.
- Nurturing Growth and Potential: Through his leadership positions, Scott has often emphasized team empowerment and strategic partnerships, fostering collaborative environments that nurture creativity and drive progress in product development.
- Legacy of Leadership: Scott's leadership ethos and hands-on approach to management have left a lasting impact on the companies he has led, often resulting in successful exits for investors and enhanced brand reputations in the industry.
Scott Glenn embodies the qualities of a visionary entrepreneur, his extensive experience, and accomplishments in the life sciences sector showcase not just professional success but a dedication to transforming healthcare for the better. He continues to inspire many within the industry, proving that thoughtful leadership and innovation can significantly influence the well-being of individuals worldwide.
Highlights

